Photo illustration of chronic myeloid leukemia molecules

ARUP Consult®, a free source of laboratory testing information for clinicians, released several new and updated resources in March.

April 4, 2023

ARUP Consult Provides Updated Resources on Testing for Chronic Myeloid Leukemia and…

ARUP Consult, a free source of expert guidance in laboratory testing, has released updated

Steven Baker stands in a research laboratory.

ARUP Associate Medical Director Steven Baker, MD, PhD, will lead research that aims to determine whether gene therapies can be developed to treat patients living with creatine transporter deficiency (CTD).

March 15, 2023

ARUP Medical Directors Seek New Diagnostic Tools, Treatment for Creatine…

Drawing on ARUP experts' extensive knowledge about the diagnosis and treatment of cerebral

Rong Mao looks out over a balcony.

Rong Mao, MD, FACMG, has been elected to the American College of Medical Genetics and Genomics (ACMG) Foundation board of directors. Her two-year term will begin with the ACMG annual meeting on March 14, 2023.

March 10, 2023

Rong Mao Will Join ACMGF Board of Directors and Present Research at ACMG 2023 Meeting

Rong Mao, MD, FACMG, looks forward to bridging the gap between laboratory and clinical practice after her recent

photo of genome sequencing

ARUP Consult®, a free source of laboratory testing information for clinicians, released new and updated resources in February.

March 7, 2023

ARUP Consult Provides Updated Resources on Testing for Complement Deficiency and Hereditary…

ARUP Consult, a free source of expert guidance in laboratory testing, has released

Ethan Bruns and Andy Theurer

Ethan Bruns (left), a University of Utah biology student living with atypical hemolytic uremic syndrome, joined ARUP CEO Andy Theurer at a Rare Disease Day event in Salt Lake City on Tuesday, February 28, to raise awareness and highlight progress in the diagnosis and treatment of rare disease.

March 1, 2023

ARUP CEO Joins Healthcare Leaders, Advocacy Organizations for Rare Disease Day Event

In closing remarks at a Rare Disease Day event, ARUP CEO Andy Theurer thanked young people sharing

Stewart, Becky, Woodward, and Linden Tribe stand on a beach.

Stewart and Becky Tribe, shown here with their 2-year-old son Woodward and their 5-year-old daughter Linden, say their family benefitted greatly from newborn screening that led to their son’s early GAMT deficiency diagnosis. Woody, as he is called, has taken supplements since his birth that have prevented cognitive impairments he might have developed if the disorder had not been detected in infancy.

February 16, 2023

Advocates for Nationwide Newborn Screening for GAMT Deficiency Celebrate Important Milestone

The addition of GAMT deficiency to the federal Recommended Uniform Screening Panel is an important